Rates of Nonsteroidal Anti-Inflammatory Drug Use in Patients with Established Cardiovascular Disease: A Retrospective, Cross-Sectional Study from NHANES 2009–2010
Sign Up to like & getrecommendations! Published in 2017 at "American Journal of Cardiovascular Drugs"
DOI: 10.1007/s40256-016-0212-1
Abstract: PurposeNonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat pain, inflammation, and fever in the USA. Unfortunately, NSAIDs have been associated with an increased risk of adverse cardiovascular events, especially among NSAID users with established… read more here.
Keywords: anti inflammatory; use; established cardiovascular; study ... See more keywords
Clopidogrel monotherapy versus Aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2022 at "Thrombosis and haemostasis"
DOI: 10.1055/a-1853-2952
Abstract: BACKGROUND The is no clear consensus on whether Aspirin offers better outcomes in terms of secondary cardiovascular disease prevention compared to Clopidogrel. OBJECTIVE The aim of the study was to compare the safety and efficacy… read more here.
Keywords: cardiovascular disease; disease; patients established; monotherapy ... See more keywords
Short and long-term survival in patients hospitalized due to COVID-19 in relation to cardiovascular risk factors and established cardiovascular diseases: the Cor-Cardio Study.
Sign Up to like & getrecommendations! Published in 2023 at "Polish archives of internal medicine"
DOI: 10.20452/pamw.16441
Abstract: INTRODUCTION We aimed to analyze the influence of cardiovascular risk factors, established cardiovascular diseases and its treatment with cardiovascular drugs on short term and long term survival in patients hospitalized due to COVID-19. PATIENTS AND… read more here.
Keywords: patients hospitalized; covid; risk factors; risk ... See more keywords
412-P: Lipoprotein(a) and Vascular Risk in Patients with Established Cardiovascular Disease
Sign Up to like & getrecommendations! Published in 2020 at "Diabetes"
DOI: 10.2337/db20-412-p
Abstract: Lipoprotein(a) [Lp(a)] is an important cardiovascular risk factor especially in young individuals. However, data on the vascular risk conferred by Lp(a) in patients with established cardiovascular disease (CVD) are controversial. In particular, the power of… read more here.
Keywords: vascular risk; established cardiovascular; patients established; none ... See more keywords